Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Sylvie Rottey
Profile
Projects
Publications & Research Data
Activities
Awards & Distinctions
Patents
307
Results
2026
Heelkundige uitkomst na lymfeklierdissectie bij lokaal gevorderd renaal cel carcinoom: een retrospectieve analyse
Dries Vandendriessche
Victor Declerck
Simon Pauwelijn
Camille Berquin
Pieter De Visschere
Sofie Verbeke
Sylvie Rottey
Karel Decaestecker
Nicolaas Lumen
Charles Van Praet
U
Journal Article
in
Tijdschrift voor Geneeskunde
2026
2025
A comprehensive view of N-glycosylation as clinical biomarker in prostate cancer
Lissa Eggermont
Nicolaas Lumen
Charles Van Praet
Joris Delanghe
Sylvie Rottey
Tijl Vermassen
A1
Journal Article
in
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
2025
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer
Pieter-Jan Volders
Philippe Aftimos
Franceska Dedeurwaerdere
Geert Martens
Jean-Luc Canon
Gabriela Beniuga
Guy Froyen
Jacques Van Huysse
Rebecca De Pauw
Hans Prenen
et al.
A1
Journal Article
in
NPJ PRECISION ONCOLOGY
2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors : a phase 1 trial
Juanita Lopez
Thomas Powles
Fadi Braiteh
Lillian L. Siu
Patricia LoRusso
Claire F. Friedman
Ani S. Balmanoukian
Michael Gordon
Jeffrey Yachnin
Sylvie Rottey
et al.
A1
Journal Article
in
NATURE MEDICINE
2025
Complete remission with olaparib in BRIP1-mutated metastatic high-grade pleomorphic sarcoma : case study and literature review : an example of a genomic profiling-based tumor treatment, in a cancer type with high unmet clinical need
Alexander Thooft
Sofie Joris
Celine Jacobs
David Creytens
Sylvie Rottey
Brigitte Maes
Philippe Aftimos
Lore Lapeire
A1
Journal Article
in
ACTA ONCOLOGICA
2025
Early markers of sensorineural hearing loss after platinum-based chemotherapy
Heleen Van Der Biest
Sarineh Keshishzadeh
Hannah Keppler
Eline Naert
Sylvie Rottey
Ingeborg Dhooge
Sarah Verhulst
A1
Journal Article
in
EAR AND HEARING
2025
Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors
Michaël Henrotte
David Creytens
Filip De Vos
Benedicte Descamps
Lindsey Devisscher
Gabriële Holtappels
Wouter Huvenne
Ken Kersemans
Amber Meskens
Sara Neyt
et al.
C3
Conference
2025
Immune checkpoint-induced colitis : a single-center retrospective cohort study
Bengt Van Holder
Julie Vereecke
Nathan Ureel
Triana Lobatón Ortega
Anne Hoorens
Amber Lievens
Marie Truyens
Sylvie Rottey
Karim Vermaelen
Venita D'Cruz
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL MEDICINE
2025
Monitoring platinum-induced ototoxicity in adults : early and long-term audiovestibular outcomes
Heleen Van Der Biest
Sarah Verhulst
Hannah Keppler
Eline Naert
Sylvie Rottey
Frederic Acke
Ingeborg Dhooge
C3
Conference
2025
Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors : should we treat beyond two years?
Alexander Decruyenaere
Christine Gennigens
Sylvie Rottey
Annouschka Laenen
Emmanuel Seront
Els Everaert
Philip R Debruyne
Heidi Van Den Bulck
Julie Bastin
Annelies Verbiest
et al.
A1
Journal Article
in
ACTA ONCOLOGICA
2025
Prognostication of brain-metastasized patients receiving subsequent systemic therapy : a single-center long-term follow-up
Tijl Vermassen
Charlotte Van Parijs
Stijn De Keukeleire
Katrien Vandecasteele
Sylvie Rottey
A1
Journal Article
in
CURRENT ONCOLOGY
2025
Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma
Michaël Henrotte
David Creytens
Filip De Vos
Benedicte Descamps
Lindsey Devisscher
Wouter Huvenne
Ken Kersemans
Sara Neyt
Sylvie Rottey
Michael Saerens
et al.
C3
Conference
2025
The accuracy of PSMA PET/CT for assessing intraprostatic lesions in patients with prostate cancer: An evaluation of the PI-RADS, PRIMARY and PSMA-expression score
Eva Donck
Pieter De Visschere
Charles Van Praet
Sofie Verbeke
Sifrid Hendrickx
Camille Berquin
Sylvie Rottey
Wesley Verla
Nicolaas Lumen
U
Journal Article
in
Belgian Journal of Medical Oncology
2025
2024
A phase I study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer
Tanya Dorff
Lisa G. Horvath
Karen Autio
Alice Bernard-Tessier
Matthew B. Rettig
Jean-Pascal Machiels
Mehmet A. Bilen
Martijn P. Lolkema
Nabil Adra
Sylvie Rottey
et al.
A1
Journal Article
in
CLINICAL CANCER RESEARCH
2024
A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants
Pranav Gupta
Manash Chatterjee
Yeonil Kim
Kathleen Deschamps
Lieselotte Lemoine
Kristien Van Dyck
Catherine Zhou Matthews
Sylvie Rottey
Aubrey Stoch
Eseng Lai
A1
Journal Article
in
INVESTIGATIONAL NEW DRUGS
2024
Anticoagulant-related bleeding as a sign of underlying tumoural lesions in patients with atrial fibrillation: a nationwide cohort study
Kristiaan Proesmans
Maxim Grymonprez
Sylvie Rottey
Lies Lahousse
U
Journal Article
in
European Heart Journal Open
2024
Challenges in performing clinical trials in low incidence disease
Levi Hoste
Sylvie Rottey
C3
Conference
2024
Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract : a long-term comparative study
Tijl Vermassen
Stijn De Keukeleire
Michael Saerens
Sylvester Heerwegh
Jens Debacker
Wouter Huvenne
Philippe Deron
David Creytens
Liesbeth Ferdinande
Sylvie Rottey
et al.
A1
Journal Article
in
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
2024
Clinical pharmacology and pharmaceutical medicine : creation of a new specialist title for physicians in Belgium
R. Lins
P. Waterbley
B. Shivalkar
J. de Hoon
Sylvie Rottey
E. Present
A1
Journal Article
in
ACTA CLINICA BELGICA
2024
Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients
Tijl Vermassen
Karen Geboes
Nicolaas Lumen
Charles Van Praet
Sylvie Rottey
Joris Delanghe
A1
Journal Article
in
CLINICAL KIDNEY JOURNAL
2024
Discovery of the dual A2A/A2B receptor antagonist MK-1088 for the treatment of solid tumors
Duane E. DeMong
Sheila Ranganath
Jared Cumming
Matthew Larsen
Yonglian Zhang
Christopher Plummer
Amjad Ali
Anthony Palmieri
Evan Barry
Pierre Daublain
et al.
C3
Conference
2024
Divergent fates : the ambiguous role of M2-like TAMs in oropharyngeal cancer
Michael Saerens
Michel Struys
Wouter Huvenne
Sylvie Rottey
Fleur Cordier
S Fadei
David Creytens
W Waelput
Tijl Vermassen
Jens Debacker
C3
Conference
2024
Final results of a phase II study of peltopepimut-S and cemiplimab in patients with relapsed/metastatic HPV16+oropharyngeal cancer that progressed with prior anti-PD-1 therapy
A. Kong
C. Even
B. Aguilera
M. Klein Hesselink
S. Visscher
C. H. Chung
J. C. Park
D. R. Adkins
S. Salas
K. J. Harrington
et al.
C3
Conference
2024
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors : results from phase I dose exploration5
J. Rodon
H. Prenen
A. Sacher
M. Villalona-Calero
N. Penel
A. El Helali
Sylvie Rottey
N. Yamamoto
F. Ghiringhelli
M. E. Goebeler
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2024
Inference failure with synthetic arms : empirical application to phase III oncology trials
Alexander Decruyenaere
Heidelinde Dehaene
Paloma Rabaey
Charles Polet
Johan Decruyenaere
Toon Demeester
Stijn Vansteelandt
Sylvie Rottey
C3
Conference
2024
Outcomes of adjuvant immune checkpoint inhibitor therapy in melanoma : a retrospective study
Sarah Fieuws
Margot De Ridder
Valérie Baert
Alexander Decruyenaere
Lieve Brochez
Sylvie Rottey
Celine Jacobs
Michael Saerens
U
Journal Article
in
ACTA CLINICA BELGICA
2024
Phase 1b study of tarlatamab in de novo or treatment-emergent neuroendocrine prostate cancer (NEPC)
Rahul Raj Aggarwal
Sylvie Rottey
Alice Bernard-Tessier
Begona Mellado-Gonzalez
Takeo Kosaka
Walter Michael Stadler
Shahneen Sandhu
Brian Yu
Crystal Shaw
Chia-Hsin Ju
et al.
C3
Conference
2024
Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma
Loic Verlingue
Antoine Italiano
Hans Prenen
Eva Maria Guerra Alia
Diego Tosi
Ruth Perets
Iwona Lugowska
Vladimir Moiseyenko
Mahmut Gumus
Cagatay Arslan
et al.
A1
Journal Article
in
EBIOMEDICINE
2024
Phase I safety and efficacy of brenetafusp, a PRAME x CD3 ImmTAC T cell engager, in platinum resistant ovarian cancer (PROC)
C. Friedman
A. De Burgh Williams
J. S. Lopez
K. Ouali
M. R. Middleton
F. Thistlethwaite
O. Hamid
B. Izar
V. Moreno Garcia
M. L. Johnson
et al.
C3
Conference
2024
Phase I study of MCLA-145, a bispecific antibody targeting CD137 and PD-L1, in solid tumors, as monotherapy or in combination with pembrolizumab
Chrisann Kyi
Marloes Van Dongen
Sylvie Rottey
Ignacio Melero Bermejo
Diana Mittag
Dane Gouveia
Kees Bol
Chris Yan
Andrew K. Joe
Gianluca Laus
et al.
C3
Conference
2024
Potential clinical applications of current and future oral forms of desmopressin (review)
Karel Everaert
Tove Holm-Larsen
George Bou Kheir
Sylvie Rottey
Jeffrey Weiss
Johan Vande Walle
Abdo Kabarriti
Lien Dossche
François Hervé
Anne-Françoise Spinoit
et al.
A1
Journal Article
in
EXPERIMENTAL AND THERAPEUTIC MEDICINE
2024
Preliminary safety and pharmacokinetics of the MET-TKI DO-2 in patients with advanced solid tumors harboring MET aberrations : a phase I study
T. Perera
B. Sikkema
B. Dekeyser
P. de Bruijn
F. Zammit
R. Galot
J. P. Machielsjean-pascal
Brant Delafontaine
Sylvie Rottey
A. Swalduz
et al.
C3
Conference
2024
Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer
Daan De Maeseneer
Pieter De Visschere
Mats Van den broecke
Felix Delbare
Geert Villeirs
Sofie Verbeke
Valerie Fonteyne
Charles Van Praet
Karel Decaestecker
Alexander Decruyenaere
et al.
A1
Journal Article
in
BMC MEDICAL IMAGING
2024
The association between urine N-glycome and prognosis after initial therapy for primary prostate cancer
Tijl Vermassen
Nicolaas Lumen
Charles Van Praet
Nico Callewaert
Joris Delanghe
Sylvie Rottey
A1
Journal Article
in
BIOMEDICINES
2024
Weekly vs 3-weekly cisplatin : a retrospective cohort study
Michael Saerens
Alexander Van den Broeck
Geertrui Van de Weghe
Wouter Huvenne
Peter Tomassen
Wouter Bauters
Tijl Vermassen
Sarah Deschuymer
Sylvie Rottey
Fréderic Duprez
C3
Conference
2024
2023
A first-in-human, open-label, multicenter study of intratumoral SAR441000 (mixture of cytokine encoding mRNAs), as monotherapy and in combination with cemiplimab in patients with advanced solid tumors
Oliver Bechter
Carmen Loquai
Stephane Champiat
Jean Francois Baurain
Jean-Jacques Grob
Jochen Utikal
Sylvie Rottey
Alfonso Berrocal
Jessica Hassel
Ana Arance
et al.
C3
Conference
2023
A phase 1/2 study of JK08, an IL-15 antibody fusion protein targeting CTLA-4, in patients with advanced solid tumors
Nuria Kotecki
Sylvie Rottey
Elena Garralda
Maria de de Miguel
Omar Saavedra
Valentina Boni
Judit W. Johnson
Jonathan P. McNally
Mohit Mathew
Adam Hughes
et al.
C3
Conference
2023
A randomized, double-blind, placebo-controlled, phase 1 trial of radiopaque islatravir-eluting subdermal implants for pre-exposure prophylaxis against HIV-1 infection
RP Matthews
X Zang
SE Barrett
A Koynov
A Goodey
T Heimbach
VL Weissler
C Leyssens
T Reynders
Z Xu
et al.
A1
Journal Article
in
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2023
Afatinib for EGFR, HER2 or HER3 mutated solid tumors : a phase II Belgian precision study
L. Decoster
P. G. Aftimos
Sylvie Rottey
H. Prenen
J. J. Collignon
J. Mebis
J-L. Canon
V. Fastenaekels
N. Cappoen
S. R. Joris
et al.
C3
Conference
2023
Afatinib in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) harboring alterations in the HER pathway : results of the B1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
Rachel Galot
Christophe Le Tourneau
Lisa F. Licitra
Amaury Daste
Caroline Even
Esma Saada-Bouzid
Stephanie Henry
Sylvie Rottey
Emmanuel Seront
Marie-Christine Kaminsky
et al.
C3
Conference
2023
Assessment of pharmacokinetics, safety, and tolerability following twice-daily administration of molnupiravir for 10 days in healthy participants
Marian Iwamoto
Kelly E. Duncan
Prachi K. Wickremasingha
Tian Zhao
Maria V. Liberti
Lieselotte Lemoine
Tatjana Decaesteker
Sylvie Rottey
Brian M. Maas
Gillian Gillespie
et al.
A1
Journal Article
in
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
2023
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma : dose-finding results from phase Ib of the JAVELIN PARP MEKi trial
J. Rodon Ahnert
D. S. -W Tan
I. Garrido-Laguna
W. Harb
A. Bessudo
J. T. Beck
Sylvie Rottey
N. Bahary
N. Kotecki
Z. Zhu
et al.
A1
Journal Article
in
ESMO OPEN
2023
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial
Mathieu Spaas
Nora Sundahl
Vibeke Kruse
Sylvie Rottey
Daan De Maeseneer
Fréderic Duprez
Yolande Lievens
Veerle Surmont
Lieve Brochez
Dries Reynders
et al.
A1
Journal Article
in
JAMA ONCOLOGY
2023
GeNeo : agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative
P. G. Aftimos
K. Punie
L. Decoster
C. Van Marcke de Lummen
A. Hebrant
G. Raicevic
E. Van Valckenborgh
B. Maes
J. Maetens
J. J. Collignon
et al.
C3
Conference
2023
Immunotherapeutic targeting and PET imaging of DLL3 in small-cell neuroendocrine prostate cancer
Jonathan Chou
Emily A. Egusa
Sinan Wang
Michelle L. Badura
Fei Lee
Anil P. Bidkar
Jun Zhu
Tanushree Shenoy
Kai Trepka
Troy M. Robinson
et al.
A1
Journal Article
in
CANCER RESEARCH
2023
Incidence, evolution and risk factors of hypophosphatemia in patients with solid tumors receiving ferric carboxymaltose : a retrospective cohort study
Alexander Decruyenaere
Koen Kortbeek
Sigurd Delanghe
Sylvie Rottey
Hannelore Denys
Lore Lapeire
A1
Journal Article
in
ACTA CLINICA BELGICA
2023
Infrared spectroscopy : a new frontier in hematological disease diagnosis
Charlotte Delrue
Reinhart Speeckaert
Matthijs Oyaert
Tessa Kerre
Sylvie Rottey
Renaat Coopman
Wouter Huvenne
Sander De Bruyne
Marijn Speeckaert
A1
Journal Article
in
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2023
Initial results from first-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in biomarker-selected solid tumors
Jordi Rodon
Noboru Yamamoto
Toshihiko Doi
Francois Ghiringhelli
Maria-Elisabeth Goebeler
Yutaka Fujuwara
Miguel Villalona-Calero
Nicolas Penel
Amita Patnaik
Jean-Pascal Machiels
et al.
C3
Conference
2023
Long-term outcomes and surgical complications of endonasal endoscopic surgery in ITAC
Micky Saerens
Tijl Vermassen
Stijn De Keukeleire
Jens Debacker
Fréderic Duprez
Philippe Deron
Wouter Huvenne
David Creytens
Sylvie Rottey
Thibaut Van Zele
C3
Conference
2023
Monoclonal antibodies against GFR α 3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain
Selin Somersan-Karakaya
Kenneth C. Turner
Luz Cortes-Burgos
Jutta Miller
Michael LaCroix-Fralish
Veronika Logovinsky
Yamini Patel
Richard Torres
Samit Ganguly
Aurora Breazna
et al.
A2
Journal Article
in
NEUROBIOLOGY OF PAIN
2023
PD-L1 expression in different non-clear cell renal cell carcinoma subtypes : an analysis of the SUNNIFORECAST cohort
M. Ahrens
L. Vorfelder
C. Stoehr
J. Haanen
B. Escudier
Gross M. Goupil
E. Boleti
G. Gravis
M. -O Grimm
S. Negrier
et al.
C3
Conference
2023
Phase I, non-randomised, open-label, multi-centre dose escalation trial of BI 764532 (DLL3/CD3 IgG-like T cell engager [TcE]) plus ezabenlimab (anti-PD-1 antibody) in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs) expressing DLL3
J. Mazieres
M. Duruisseaux
H. Curcio
C. Morizane
R. Galot
Sylvie Rottey
J. A. Stratmann
Y. Ma
M. Bouzaggou
L. Geng
et al.
C3
Conference
2023
Phase I/II study of JK08, an IL-15 antibody fusion protein targeting CTLA-4, with unresectable locally advanced or metastatic cancer
N. Kotecki
Sylvie Rottey
E. Garralda
V. Galvao
M. J. De Miguel Luken
O. Saavedra Santa Gadea
V. Boni
J. Johnson
J. P. McNally
A. McEwen
et al.
C3
Conference
2023
Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours
Patrick Schoffski
Jean -Pascal Machiels
Sylvie Rottey
Behbood Sadrolhefazi
Hanny Musa
Kristell Marzin
Ahmad Awada
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2023
Single ascending doses of REGN7999, a monoclonal antibody inhibitor of TMPRSS6, increase serum hepcidin and cause deep, sustained reductions in serum iron in healthy human volunteers
Sylvie Rottey
Nikhil Singh
Emily Labriola-Tompkins
Heinrich E Lob
Kusha Mohammadi
Hazem Hassan
Lorna Farrelly
Swati Duggal
Harvey Chin
Sarah Hatsell
et al.
C3
Conference
2023
2022
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib
Ahmad Awada
Thierry Berghmans
Paul M. Clement
Kristof Cuppens
Bram De Wilde
Jean-Pascal Machiels
Patrick Pauwels
Marc Peeters
Sylvie Rottey
Eric Van Cutsem
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2022
Cabozantinib plus atezolizumab in advanced head and neck cancer previously treated with platinum-containing chemotherapy : results from cohort 17 of the COSMIC-021 study
Sylvie Rottey
Armando Santoro
Suzanne Arnold
Saad Khan
Allen Cohn
Bruno Fang
Svetlana Andrianova
Ramu Sudhagoni
Leleesha Samaraweera
Maria Gonzalez-Cao
C3
Conference
2022
Concordance, correlation, and clinical impact of standardized PD-L1 and TIL scoring in SCCHN
Stijn De Keukeleire
Tijl Vermassen
Philippe Deron
Wouter Huvenne
Fréderic Duprez
David Creytens
Jo Van Dorpe
Liesbeth Ferdinande
Sylvie Rottey
A1
Journal Article
in
CANCERS
2022
Cytoreductive nephrectomy and exposure to sunitinib : a post hoc analysis of the immediate surgery or surgery after sunitinib malate in treating patients with metastatic kidney cancer (SURTIME) trial
Yasmin Abu‐Ghanem
Johannes V. Thienen
Christian Blank
Maureen J. B. Aarts
Michael Jewett
Igle Jan Jong
Jean‐Baptiste Lattouf
Harm H. E. Melick
Lori Wood
Peter Mulders
et al.
A1
Journal Article
in
BJU INTERNATIONAL
2022
Dissecting TILs and PD-L1 in head and neck cancer : (still) ready for clinical practice?
Stijn De Keukeleire
Sylvie Rottey
Liesbeth Ferdinande
Dissertation
2022
Highlights in genitourinary cancer
Tijl Vermassen
Alexander Decruyenaere
Sylvie Rottey
Daan De Maeseneer
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2022
Highlights in genitourinary cancers
Alexander Decruyenaere
Sylvie Rottey
Daan De Maeseneer
Tijl Vermassen
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2022
Isatuximab plus atezolizumab in patients with advanced solid tumors : results from a phase I/II, open-label, multicenter study
M. Simonelli
E. Garralda
F. Eskens
M. Gil-Martin
C-J Yen
R. Obermannova
Y. Chao
S. Lonardi
B. Melichar
V Moreno
et al.
A1
Journal Article
in
ESMO OPEN
2022
KEYNOTE-B79 phase 1b trial to evaluate the allogeneic CAR T-cells CYAD-101 and pembrolizumab in refractory metastatic colorectal cancer patients
Richard D. Kim
Hans Prenen
Sylvie Rottey
Dae Won Kim
Anne Flament
Frederic Lehmann
Eric Van Cutsem
C3
Conference
2022
Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study
Emiel De Jaeghere
Heini Kanervo
Roos Colman
Wim Schrauwen
Paulien West
Nele Vandemaele
Aglaja De Pauw
Celine Jacobs
Ingeborg Hilderson
Michael Saerens
et al.
A1
Journal Article
in
CANCERS
2022
Novel antibody cocktail targeting Bet v 1 rapidly and sustainably treats birch allergy symptoms in a Phase 1 study
Philippe Gevaert
Jarno De Craemer
Natalie De Ruyck
Sylvie Rottey
Jan de Hoon
Peter W. Hellings
Bram Volckaert
Kristof Lesneuck
Jamie M. Orengo
Amanda Atanasio
et al.
A1
Journal Article
in
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
2022
Phase I/IIa trial of BMS-986148, an anti-mesothelin antibody–drug conjugate, alone or in combination with nivolumab in patients with advanced solid tumors
Sylvie Rottey
Jeffrey Clarke
Kyaw Aung
Jean-Pascal Machiels
Ben Markman
Kimberley M. Heinhuis
Michael Millward
Martijn Lolkema
Sandip Pravin Patel
Paul de Souza
et al.
A1
Journal Article
in
CLINICAL CANCER RESEARCH
2022
PRECISION : the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment
J. Thouvenin
C. Van Marcke
L. Decoster
G. Raicevic
K. Punie
M. Vandenbulcke
R. Salgado
E. Van Valckenborgh
B. Maes
S. Joris
et al.
A1
Journal Article
in
ESMO OPEN
2022
Safety and tolerability of topical polyhexamethylene biguanide : a randomised clinical trial in healthy adult volunteers
Vincenzo Papa
Ivanka van der Meulen
Sylvie Rottey
Guy Sallet
Jolanda Overweel
Nino Asero
Darwin C Minassian
John K G Dart
A1
Journal Article
in
BRITISH JOURNAL OF OPHTHALMOLOGY
2022
Short and medium-term outcomes of patients with solid cancer hospitalized with COVID-19 in Belgium according to cancer diagnosis and treatment characteristics
Tatjana Geukens
Mariana Brandao
Marjolein Heijlen
Joelle Collignon
Cedric Van Marcke
Ingrid Louviaux
Wim Demey
Simon Van Wambeke
Sylvie Lecomte
Dominique Van Beckhoven
et al.
C3
Conference
2022
TEARDRoP Oncology : BBRMI.be workshop on sustainability
Liselot Mus
Bram De Wilde
Catherine Van Der Straeten
Barbara De Moerloose
Sandra Jacobs
Sylvie Rottey
Marie-Francoise Dresse
Ilse De Reze
C3
Conference
2022
TEARDRoP oncology : good practices for paediatric biobanking
Liselot Mus
Bram De Wilde
Catherine Van Der Straeten
Barbara De Moerloose
Sandra Jacobs
Sylvie Rottey
Marie-Francoise Dresse
Ilse De Reze
C3
Conference
2022
The TEARDRoP (Team early drug development in Paediatric oncology) consortium : to help Research find its way to improved treatments for children with cancer
Liselot Mus
Bram De Wilde
Catherine Van Der Straeten
Barbara De Moerloose
Sandra Jacobs
Sylvie Rottey
Marie-Francoise Dresse
Ilse De Reze
C3
Conference
2022
The therapeutic landscape of salivary gland malignancies : where are we now?
Robbert Cleymaet
Tijl Vermassen
Renaat Coopman
Hubert Vermeersch
Stijn De Keukeleire
Sylvie Rottey
A1
Journal Article
in
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
The use of national reimbursement reports to support formulary decisions of the hospital's Drug and Therapeutics Committee : a comparative analysis
Barbara Claus
SABRINA COMMEYNE
Marc Van de Casteele
Sylvie Rottey
A1
Journal Article
in
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
2022
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial
Jan Vanwelkenhuyzen
Mathieu Spaas
Kim Van der Eecken
Vibeke Kruse
Sylvie Rottey
Lieve Brochez
Johan Lindberg
Katleen De Preter
Bram De Laere
Piet Ost
C3
Conference
2022
Tumor-infiltrating lymphocytes in head and neck cancer : ready for prime time?
Alhadi Almangush
Stijn De Keukeleire
Sylvie Rottey
Liesbeth Ferdinande
Tijl Vermassen
Ilmo Leivo
Antti A. Makitie
A1
Journal Article
in
CANCERS
2022
2021
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors
Gerald S. Falchook
Marc Peeters
Sylvie Rottey
Luc Y. Dirix
Radka Obermannova
Jonathan E. Cohen
Ruth Perets
Ronnie Shapira Frommer
Todd M. Bauer
Judy S. Wang
et al.
A1
Journal Article
in
INVESTIGATIONAL NEW DRUGS
2021
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck : the I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial
Rachel Galot
Christophe Le Tourneau
Esma Saada-Bouzid
Amaury Daste
Caroline Even
Philip Debruyne
Stéphanie Henry
Sylvie Zanetta
Anemie Rutten
Lisa Licitra
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2021
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck : the RESGEX study
K. Klinghammer
J. Fayette
A. Kawecki
A. Dietz
P. Schafhausen
G. Folprecht
Sylvie Rottey
P. Debourdeau
J. Lavernia
A. Jacobs
et al.
A1
Journal Article
in
ESMO OPEN
2021
An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma
Astrid De Meulenaere
Tijl Vermassen
David Creytens
Stijn De Keukeleire
Tim Delahaye
Philippe Deron
Fréderic Duprez
Samson Fung
Patrick Pauwels
Liesbeth Ferdinande
et al.
A1
Journal Article
in
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
2021
Anthracyclines strike back : rediscovering non-pegylated liposomal doxorubicin in current therapeutic scenarios of breast cancer
Francesco Schettini
Mario Giuliano
Matteo Lambertini
Rupert Bartsch
David James Pinato
Concetta Elisa Onesti
Nadia Harbeck
Diana Lueftner
Sylvie Rottey
Peter A. van Dam
et al.
A1
Journal Article
in
CANCERS
2021
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial
Mathieu Spaas
Nora Sundahl
Eva Hulstaert
Vibeke Kruse
Sylvie Rottey
Daan De Maeseneer
Veerle Surmont
Annabel Meireson
Lieve Brochez
Dries Reynders
et al.
A1
Journal Article
in
BMC CANCER
2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
Jozefien Declercq
Karel Van Damme
Elisabeth De Leeuw
Bastiaan Maes
Cedric Bosteels
Simon Tavernier
Stefanie De Buyser
Roos Colman
Maya Hites
Gil Verschelden
et al.
A1
Journal Article
in
LANCET RESPIRATORY MEDICINE
2021
Effectiveness of adjunctive analgesics in head and neck cancer patients receiving curative (chemo-) radiotherapy : a systematic review
Tessa Lefebvre
Laura Tack
Michelle Lycke
Fréderic Duprez
Laurence Goethals
Sylvie Rottey
Lieselot Cool
Koen Van Eygen
Brendon Stubbs
Patricia Schofield
et al.
A1
Journal Article
in
PAIN MEDICINE
2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial
Flor Verghote
Lindsay Poppe
Sofie Verbeke
Piet Dirix
Maarten Albersen
Gert De Meerleer
Charlien Berghen
Piet Ost
Geert Villeirs
Pieter De Visschere
et al.
A1
Journal Article
in
BMC CANCER
2021
Expected medium- and long-term impact of the COVID-19 outbreak in oncology
Concetta Elisa Onesti
Marco Tagliamento
Giuseppe Curigliano
Nadia Harbeck
Rupert Bartsch
Hans Wildiers
Vivianne Tjan-Heijnen
Miguel Martin
Sylvie Rottey
Daniele Generali
et al.
A2
Journal Article
in
JCO GLOBAL ONCOLOGY
2021
Favorable survival for endonasal endoscopic resection in locally advanced sinonasal intestinal type adenocarcinoma : a long-term comparative study
Stijn De Keukeleire
Jens Debacker
Tijl Vermassen
Fréderic Duprez
Philippe Deron
Wouter Huvenne
David Creytens
Sylvie Rottey
Thibaut Van Zele
C3
Conference
2021
Het traject van een patiënt met een hoofd- en halsmaligniteit in België
Frederick Dochy
Philippe Deron
Peter Tomassen
Fréderic Duprez
Sylvie Rottey
Celine Jacobs
A. De Prins
J. Saelens
Wouter Huvenne
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2021
Highlights in genitourinary cancers
Tijl Vermassen
Sylvie Rottey
Daan De Maeseneer
Other
2021
Immune checkpoint inhibitors in treatment of soft-tissue sarcoma : a systematic review and meta-analysis
Michael Saerens
Nele Brusselaers
Sylvie Rottey
Alexander Decruyenaere
David Creytens
Lore Lapeire
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2021
Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures
Annabel Meireson
Simon Tavernier
Sofie Van Gassen
Nora Sundahl
Annelies Demeyer
Mathieu Spaas
Vibeke Kruse
Liesbeth Ferdinande
Jo Van Dorpe
Benjamin Hennart
et al.
A1
Journal Article
in
CANCERS
2021
Immuno-oncological biomarkers for squamous cell cancer of the head and neck : current state of the art and future perspectives
Stijn De Keukeleire
Tijl Vermassen
Elien Hilgert
David Creytens
Liesbeth Ferdinande
Sylvie Rottey
A1
Journal Article
in
CANCERS
2021
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial
Mathieu Spaas
Nora Sundahl
Sylvie Rottey
VIBEKE KRUSE
Daan De Maeseneer
Fréderic Duprez
Piet Dirix
Veerle Surmont
Yolande Lievens
Robin Van den Begin
et al.
C3
Conference
2021
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?
Stijn De Keukeleire
Tijl Vermassen
Zahra Mosala Nezhad
Tessa Kerre
Vibeke Kruse
Hans Van Vlierberghe
Karim Vermaelen
Sylvie Rottey
A1
Journal Article
in
IMMUNOTHERAPY
2021
Prognostic features of near-infrared spectroscopy following primary radical prostatectomy
Tijl Vermassen
Jonas Himpe
Renaat Coopman
Charles Van Praet
Nicolaas Lumen
Sylvie Rottey
Joris Delanghe
A1
Journal Article
in
CANCERS
2021
Retrospective analysis of mpMRI to predict complete pathologic response after neo-adjuvant chemotherapy for muscle invasive bladder cancer
Daan De Maeseneer
Pieter De Visschere
Mats Van den broecke
Geert Villeirs
Karel Decaestecker
Sylvie Rottey
C3
Conference
2021
Safety and immunogenicity of LY3415244, a bispecific antibody against TIM-3 and PD-L1, in patients with advanced solid tumors
Matthew D. Hellmann
Nicoletta Bivi
Boris Calderon
Toshio Shimizu
Brant Delafontaine
Zhuqing Tina Liu
Anna M. Szpurka
Victoria Copeland
F. Stephen Hodi
Sylvie Rottey
et al.
A1
Journal Article
in
CLINICAL CANCER RESEARCH
2021
Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis : a randomized, placebo-controlled phase 1 trial
Randolph P. Matthews
Munjal Patel
Stephanie E. Barrett
Liesbeth Haspeslagh
Tom Reynders
Saijuan Zhang
Sylvie Rottey
Adrian Goodey
Ryan C. Vargo
Jay A. Grobler
et al.
A1
Journal Article
in
NATURE MEDICINE
2021
Safety, pharmacokinetics, and efficacy of budigalimab with rovalpituzumab tesirine in patients with small cell lung cancer
Emiliano Calvo
Alexander Spira
María de Miguel
Shunsuke Kondo
Anas Gazzah
Michael Millward
Hans Prenen
Sylvie Rottey
Lydia Warburton
Tuomo Alanko
et al.
A2
Journal Article
in
CANCER TREATMENT AND RESEARCH COMMUNICATIONS
2021
Selective oral MEK1/2 inhibitor pimasertib : a phase I trial in patients with advanced solid tumors
Jean-Pierre Delord
Antoine Italiano
Ahmad Awada
Philippe Aftimos
Nadine Houédé
Céleste Lebbé
Celine Pages
Thierry Lesimple
Monica Dinulescu
Jan H. M. Schellens
et al.
A1
Journal Article
in
TARGETED ONCOLOGY
2021
Selective oral MEK1/2 inhibitor pimasertib in metastatic melanoma : antitumor activity in a phase I, dose-escalation trial
Céleste Lebbé
Antoine Italiano
Nadine Houédé
Ahmad Awada
Philippe Aftimos
Thierry Lesimple
Monica Dinulescu
Jan H. M. Schellens
Suzanne Leijen
Sylvie Rottey
et al.
A1
Journal Article
in
TARGETED ONCOLOGY
2021
The NHance® mutation-equipped anti-MET antibody ARGX-111 displays increased tissue penetration and anti-tumor activity in advanced cancer patients
Philippe Aftimos
Christian Rolfo
Sylvie Rottey
Philippe Barthélémy
Christophe Borg
Keunchil Park
Do-Youn Oh
Sang-We Kim
Natalie De Jonge
Valérie Hanssens
et al.
A1
Journal Article
in
BIOMEDICINES
2021
The role of cytoreductive radical prostatectomy in the treatment of newly diagnosed low-volume metastatic prostate cancer : results from the local treatment of metastatic prostate cancer (LoMP) registry
Nicolaas Lumen
Elise De Bleser
Sarah Buelens
Wesley Verla
Filip Poelaert
Wietse Claeys
Valerie Fonteyne
Sofie Verbeke
Geert Villeirs
Kathia De Man
et al.
A1
Journal Article
in
EUROPEAN UROLOGY OPEN SCIENCE
2021
Tissue N-linked glycosylation as potential prognostic biomarker for biochemical recurrence-free survival
Tijl Vermassen
Arne Van den Broeck
Nicolaas Lumen
Nico Callewaert
Sylvie Rottey
Joris Delanghe
A1
Journal Article
in
BIOMARKERS
2021
Tumour infiltrating lymphocytes in oropharyngeal carcinoma : prognostic value and evaluation of a standardised method
Stijn De Keukeleire
Tijl Vermassen
Astrid De Meulenaere
Philippe Deron
Wouter Huvenne
Fréderic Duprez
David Creytens
Jo Van Dorpe
Sylvie Rottey
Liesbeth Ferdinande
A1
Journal Article
in
PATHOLOGY
2021
Verrucous hyperplasia and verrucous carcinoma in head and neck : use and benefit of methotrexate
Stijn De Keukeleire
Astrid De Meulenaere
Philippe Deron
Wouter Huvenne
Fréderic Duprez
Olivier Bouckenooghe
Liesbeth Ferdinande
David Creytens
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2021
2020
'In-house' data on the outside : a mobile health approach
Qinlei Huang
Tami Crumley
Christina Walters
Liesbeth Cluckers
Ingeborg Heirman
Radha Railkar
Gaurav Bhatia
Matthew Cantor
Christopher Benko
Elena S Izmailova
et al.
A1
Journal Article
in
CLINICAL PHARMACOLOGY & THERAPEUTICS
2020
A phase 1 study of mTORC1/2 inhibitor BI 860585 as a single agent or with exemestane or paclitaxel in patients with advanced solid tumors
Filippo de Braud
Jean-Pascal H. Machiels
Daniela Boggiani
Sylvie Rottey
Matteo Duca
Marie Laruelle
Stefania Salvagni
Silvia Damian
Lore Lapeire
Marcello Tiseo
et al.
A1
Journal Article
in
CANCERS
2020
A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
Juanita S. Lopez
Ross Camidge
Marco Iafolla
Sylvie Rottey
Martin Schuler
Matthew Hellmann
Ani Balmanoukian
Luc Dirix
Michael Gordon
Ryan Sullivan
et al.
C3
Conference
2020
A randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (Suniforecast)
Marit Ahrens
Bernard Escudier
Ekaterini Boleti
Marc-Oliver Grimm
Marine Gross Goupir
Pilippe Barthelemy
Gwenaelle Gravis
Jens Bedekes
Philipp Ivanyi
Andrej Panic
et al.
C3
Conference
2020
An update on the management of metastatic clear-cell renal cell carcinoma : the BSMO expert panel recommendations
Brant Delafontaine
C. De Backer
B. Beuselinck
P. Debruyne
L. D’Hondt
C. Gennigens
T. Gil
C. Vulsteke
N. Martinez-Chanza
A. Verbiest
et al.
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2020
Drug development from bench to bedside @UZGENT
Johan Vande Walle
Sylvie Rottey
Bram De Wilde
C3
Conference
2020
Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck : a case series of five patients
Karen Couvreur
Celine Jacobs
Marlies De Bock
Randal D'Hondt
Philippe Deron
Fréderic Duprez
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2020
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19 : a nationwide, population-based analysis
Evandro de Azambuja
Mariana Brandao
Hans Wildiers
Annouschka Laenen
Sandrine Aspeslagh
Christel Fontaine
Joelle Collignon
Willem Lybaert
Jolanda Verheezen
Annemie Rutten
et al.
A1
Journal Article
in
ESMO OPEN
2020
On-target pharmacodynamic activity of the PI3K inhibitor copanlisib in paired biopsies from patients with malignant lymphoma and advanced solid tumors
Franck Morschhauser
Jean-Pascal Machiels
Gilles Salles
Sylvie Rottey
Simon A. J. Rule
David Cunningham
Frederic Peyrade
Christophe Fruchart
Hendrik-Tobias Arkenau
Isabelle Genvresse
et al.
A1
Journal Article
in
MOLECULAR CANCER THERAPEUTICS
2020
Oncological care organisation during COVID-19 outbreak
Concetta Elisa Onesti
Hope S. Rugo
Daniele Generali
Marc Peeters
Khalil Zaman
Hans Wildiers
Nadia Harbeck
Miguel Martin
Massimo Cristofanilli
Javier Cortes
et al.
A1
Journal Article
in
ESMO OPEN
2020
Phase 1 study of AMG 160, a half-life extended BITE (R) (bispecific T-cell engager) therapy targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer
Tanya Dorff
Matthew Rettig
Jean-Pascal Machiels
Martijn Lolkema
Karen Autio
Richard Greil
Sylvie Rottey
Nabil Adra
Mark Salvati
Shirley Poon
et al.
C3
Conference
2020
Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting prostate-specific membrane antigen, in patients with metastatic castration-resistant prostate cancer (mCRPC).
Ben Tran
Lisa Horvath
Matthew Rettig
Karim Fizazi
Martijn P. Lolkema
Tanya B. Dorff
Richard Greil
Jean-Pascal H. Machiels
Karen A. Autio
Sylvie Rottey
et al.
C3
Conference
2020
Radiologic extranodal extension and outcome in cN + D TNM-8 stage I human papillomavirus-mediated oropharyngeal cancer : in regard to Billfalk-Kelly et al.
Fréderic Duprez
David Creytens
Wilfried De Neve
Philippe Deron
Wouter Huvenne
Sylvie Rottey
Peter Tomassen
A1
Journal Article
in
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020
Safety, tolerability, and potential clinical activity of a glucocorticoid-induced TNF receptor-related protein agonist alone or in combination with nivolumab for patients with advanced solid tumors : a phase 1/2a dose-escalation and cohort-expansion clinical trial
Kimberley M Heinhuis
Matteo Carlino
Markus Joerger
Massimo Di Nicola
Tarek Meniawy
Sylvie Rottey
Victor Moreno
Anas Gazzah
Jean-Pierre Delord
Luis Paz-Ares
et al.
A1
Journal Article
in
JAMA ONCOLOGY
2020
Targeting FGFR in bladder cancer : ready for clinical practice?
Stijn De Keukeleire
Daan De Maeseneer
Celine Jacobs
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2020
To treat or not to treat? Managing comorbidities in cancer patients under immune checkpoint inhibition
Stijn De Keukeleire
Tijl Vermassen
Gert De Schoenmakere
Vibeke Kruse
Karim Vermaelen
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2020
2019
A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
Jean-Pascal Machiels
Ramon Salazar
Sylvie Rottey
Ignacio Duran
Luc Dirix
Karen Geboes
Christine Wilkinson-Blanc
Gillian Pover
Simon Alvis
Brian Champion
et al.
A1
Journal Article
in
JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019
A phase Ia/b study of TIM-3/PD-L1 bispecific antibody in patients with advanced solid tumors
Matthew David Hellmann
Toshio Shimizu
Toshihiko Doi
F. Stephen Hodi
Sylvie Rottey
Philippe Georges Aftimos
Zhuqing Tina Liu
Nieves Velez de Mendizabal
Anna M. Szpurka
Yongzhe Piao
et al.
C3
Conference
2019
A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) : results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R Galot
C Le Tourneau
E Saada-Bouzid
A Daste
C Even
PR Debruyne
S Henry
S Zanetta
A Rutten
LF Licitra
et al.
C3
Conference
2019
Algorithms for molecular testing in solid tumours
A. Hébrant
M. Lammens
C. Van den Broecke
N. D’Haene
J. Van den Oord
A. Vanderstichele
A. Dendooven
P. Neven
K. Punie
G. Floris
et al.
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2019
Brain metastasis and renal cell carcinoma : prognostic scores assessment in the era of targeted therapies
Ziad El Ali
Sylvie Rottey
Philippe Barthelemy
Nuria Kotecki
Ruben Van Paemel
Daniel Devrient
Ahmad Awada
Thierry Gil
Diane Pannier
Thomas Ryckewaert
et al.
A1
Journal Article
in
ANTICANCER RESEARCH
2019
Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer
Ronald de Wit
Johann de Bono
Cora N. Sternberg
Karim Fizazi
Bertrand Tombal
Christian Wülfing
Gero Kramer
Jean-Christophe Eymard
Aristotelis Bamias
Joan Carles
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2019
Chimeric antigen receptor-T cells for targeting solid tumors : current challenges and existing strategies
Lorraine Springuel
Caroline Lonez
Bertrand Alexandre
Eric Van Cutsem
Jean-Pascal H. Machiels
Marc Van Den Eynde
Hans Prenen
Alain Hendlisz
Leila Shaza
Javier Carrasco
et al.
A1
Journal Article
in
BIODRUGS
2019
Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib : the SURTIME randomized clinical trial
Axel Bex
Peter Mulders
Michael Jewett
John Wagstaff
Johannes V van Thienen
Christian U Blank
Roland van Velthoven
Maria del Pilar Laguna
Lori Wood
Harm HE van Melick
et al.
A1
Journal Article
in
JAMA ONCOLOGY
2019
European Federation for Exploratory Medicines Development Lyon Conference 2019 : the changing landscape of early medicines development : be prepared
Tim Hardman
Henri Caplain
Sylvie Rottey
Desiree Douglas
Steffan Stringer
Hildegard Sourgens
A1
Journal Article
in
FRONTIERS IN PHARMACOLOGY
2019
Highlights in genitourinary cancers
Tijl Vermassen
Sylvie Rottey
Other
2019
Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer
Sarah Buelens
Elise De Bleser
Bert Dhondt
Wesley Verla
Karel Decaestecker
Piet Ost
Valerie Fonteyne
Kathia De Man
CHLOE STANDAERT
Sylvie Rottey
et al.
A1
Journal Article
in
WORLD JOURNAL OF UROLOGY
2019
Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?
Tijl Vermassen
Thierry Roumeguere
Yannick Neybuch
Lucien Hoekx
Irena Fele
Brieuc Sautois
Wouter Everaerts
Daan De Maeseneer
Frederic Lecouvet
Nicolaas Lumen
et al.
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2019
Mobile health technology captures 'in-house' data on the outside : an assessment with pharmacological intervention
G Bhatia
Q Huang
T Crumley
C Walters
L Cluckers
I Heirman
L Mixson
Sylvie Rottey
M Cantor
C Benko
et al.
C3
Conference
2019
N-Linked glycosylation and near-infrared spectroscopy in the diagnosis of prostate cancer
Tijl Vermassen
Sander De Bruyne
Jonas Himpe
Nicolaas Lumen
Nico Callewaert
Sylvie Rottey
Joris Delanghe
A1
Journal Article
in
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2019
Phase 1 study evaluating the association of the cyclin-dependent kinase 4/6 inhibitor ribociclib and cetuximab in recurrent/metastatic p16-negative squamous cell carcinoma of the head and neck
Emmanuel Seront
Sandra Schmitz
Matthias Papier
Aline van Maanen
Stéphanie Henry
Christophe Lonchay
Sylvie Rottey
Gabrielle van Caloen
Jean-Pascal Machiels
A1
Journal Article
in
FRONTIERS IN ONCOLOGY
2019
Phase I open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABBV-181 and rovalpituzumab tesirine (ROVA-T) in patients with small cell lung cancer
E Calvo
A Spira
H Prenen
Y Ohe
Sylvie Rottey
A Gazzah
M Millward
V Moreno
A Italiano
T Alanko
et al.
C3
Conference
2019
Phase Ib study of talimogene laherparepvec (T-VEC) injection into liver metastases (LMs) in combination with intravenous (IV) atezolizumab in patients (pts) with metastatic triple negative breast cancer (TNBC) or colorectal cancer (CRC).
J. Randolph Hecht
Arlene Chan
Miguel Martin
Nicolas Mach
Sara A. Hurvitz
Sylvie Rottey
Uwe Pelzer
Chunxu Liu
Emily Chan
C3
Conference
2019
Policies influencing access to new targeted oncologic drugs in Ecuadorian hospitals : an interrupted time series analysis
Carlos Durán
Monique Elseviers
Robert Vander Stichele
Sylvie Rottey
Patricia Granja
Thierry Christiaens
A2
Journal Article
in
JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH
2019
Prostate protein n-glycosylation profiling by means of DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis
Tijl Vermassen
Nico Callewaert
Sylvie Rottey
Joris Delanghe
Bookchapter
in
Clinical applications of capillary electrophoresis : methods and protocols
2019
Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results
Piet Ost
Nora Sundahl
G Vandekerkhove
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
et al.
C3
Conference
2019
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma
Nora Sundahl
Gillian Vandekerkhove
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
Jo Van Dorpe
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results
Gillian Vandekerkhove
Nora Sundahl
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
Jo Van Dorpe
et al.
C3
Conference
2019
Surgical safety of cytoreductive nephrectomy following sunitinib : results from the multicentre, randomised controlled trial of immediate versus deferred nephrectomy (SURTIME)
Roderick Emile De Bruijn
Peter Mulders
Michael A Jewett
John Wagstaff
Johan V Van Thienen
Christian U Blank
Roland Van Velthoven
Lori Wood
Harm E van Melick
Maureen J Aarts
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2019
The new first-in-human EMA guideline : disruptive or constructive? Outcomes from the first EUFEMED discussion forum
Kerstin Breithaupt-Grögler
Tim Hardman
Jan de Hoon
Yves Donazzolo
Sylvie Rottey
Hildegard Sourgens
Steffan Stringer
A1
Journal Article
in
FRONTIERS IN PHARMACOLOGY
2019
Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer : a phase 1 dose-escalation and dose-expansion study
Udai Banerji
Carla ML van Herpen
Cristina Saura
Fiona Thistiethwaite
Simon Lord
Victor Moreno
Iain R Macpherson
Valentina Boni
Christian Rolfo
Elisabeth GE de Vries
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2019
Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy
Margot Baudelet
Leen Van den Steen
Peter Tomassen
Katrien Bonte
Philippe Deron
Wouter Huvenne
Sylvie Rottey
Wilfried De Neve
Nora Sundahl
Gwen Van Nuffelen
et al.
A1
Journal Article
in
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2019
2018
A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder : is there a link between metastasis and factor deficiency in solid tumors?
Timothy Cammaert
Karel Decaestecker
Nora Sundahl
Sylvie Rottey
Katrien Devreese
A1
Journal Article
in
ANNALS OF HEMATOLOGY
2018
A feasibility study on adaptive 18F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory
Julie Schatteman
Dirk Van Gestel
Dieter Berwouts
Werner De Gersem
Geert De Kerf
Wilfried De Neve
Bie De Ost
Ana Maria Luiza Olteanu
Sylvie Rottey
Tom Vercauteren
et al.
A1
Journal Article
in
STRAHLENTHERAPIE UND ONKOLOGIE
2018
Celyad's novel CAR T-cell therapy for solid malignancies
Caroline Lonez
Alain Hendlisz
Leila Shaza
Philippe Aftimos
Michaël Vouche
Vincent Donckier
Jean-Pascal H. Machiels
Marc Van Den Eynde
Jean-Luc Canon
Javier Carrasco
et al.
A1
Journal Article
in
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE
2018
Congress highlights : ASCO 2018 special edition : highlights in genitourinary cancers
Tijl Vermassen
Sylvie Rottey
Other
2018
Congress highlights : ESMO 2018 special edition : highlights in genitourinary cancers
Tijl Vermassen
Sylvie Rottey
Other
2018
Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium
Valerie Fonteyne
Elke Rammant
Piet Ost
Yolande Lievens
Bart De Troyer
Sylvie Rottey
Gert De Meerleer
Daan De Maeseneer
Dirk De Ridder
Karel Decaestecker
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2018
Importance of choice of materials and methods in PD-L1 and TIL assessment in oropharyngeal squamous cell carcinoma
Astrid De Meulenaere
Tijl Vermassen
David Creytens
SANDRINE ASPESLAGH
Philippe Deron
Fréderic Duprez
Sylvie Rottey
Jo Van Dorpe
Liesbeth Ferdinande
A1
Journal Article
in
HISTOPATHOLOGY
2018
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing definitions of CHAARTED and LATITUDE trial
Sarah Buelens
Filip Poelaert
Bert Dhondt
Valerie Fonteyne
Pieter De Visschere
Piet Ost
Sofie Verbeke
Geert Villeirs
Kathia De Man
Sylvie Rottey
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2018
MRI in prostate cancer diagnosis, surgical or radiation treatment, focal therapy, active surveillance and follow-up
CHLOE STANDAERT
Pieter De Visschere
Sylvie Rottey
Sarah Buelens
Nora Sundahl
Geert Villeirs
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2018
Neither creatinine- nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents
Tijl Vermassen
Karen Geboes
Marc De Man
Stéphanie Laurent
Elsie Decoene
Nicolaas Lumen
Joris Delanghe
Sylvie Rottey
A1
Journal Article
in
NEPHROLOGY DIALYSIS TRANSPLANTATION
2018
Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma
Robert J. Motzer
Nizar M. Tannir
David F. McDermott
Osvaldo Arén Frontera
Bohuslav Melichar
Toni K. Choueiri
Elizabeth R. Plimack
Philippe Barthélémy
Camillo Porta
Saby George
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2018
Pembrolizumab for the treatment of bladder cancer
Nora Sundahl
Sylvie Rottey
Daan De Maeseneer
Piet Ost
A1
Journal Article
in
EXPERT REVIEW OF ANTICANCER THERAPY
2018
Pharmacokinetic and pharmacodynamic relationships of copanlisib in patients with non-Hodgkin lymphoma and advanced solid tumors
F Morschhauser
A Awada
J-P Machiels
GA Salles
Sylvie Rottey
S Rule
D Cunningham
F Peyrade
C Fruchart
H-T Arkenau
et al.
C3
Conference
2018
Pharmacokinetic effects and safety of olaparib administered with endocrine therapy : a phase I study in patients with advanced solid tumours
Ruth Plummer
Henk M. Verheul
Filip Y. F. L. De Vos
Karin Leunen
L. Rhoda Molife
Christian Rolfo
Peter Grundtvig-Sørensen
Jacques De Grève
Sylvie Rottey
Guy Jerusalem
et al.
A1
Journal Article
in
ADVANCES IN THERAPY
2018
Sharp rise in the expenditures of targeted drugs in Ecuador : five-year (2010-2014) consumption of oncologic drugs in public and private hospitals
Carlos Durán
Monique Elseviers
Robert Vander Stichele
Sylvie Rottey
Thierry Christiaens
A2
Journal Article
in
JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH
2018
2017
A phase I global trial targeting multiple solid and hematologic malignancies through a NKG2D receptor-based CAR-T immunotherapy
B Verma
A Awada
P Aftimos
P Lewalle
N Meuleman
J-P Machiels
G Catala
E Vandenneste
J Brayer
D Sallman
et al.
C3
Conference
2017
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
Nora Sundahl
Katrien De Wolf
Sylvie Rottey
Karel Decaestecker
Daan De Maeseneer
Annabel Meireson
Els Goetghebeur
Valerie Fonteyne
Sofie Verbeke
Pieter De Visschere
et al.
A1
Journal Article
in
JOURNAL OF TRANSLATIONAL MEDICINE
2017
Abscopal effect in metastatic renal cell carcinoma
Mieke Van de Walle
Jan Demol
Lorenzo Staelens
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2017
Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer
Filip Poelaert
Candy Kumps
Nicolaas Lumen
Stéphanie Verschuere
Louis Libbrecht
Marleen Praet
Sylvie Rottey
Tom Claeys
Piet Ost
Karel Decaestecker
et al.
A1
Journal Article
in
UROLOGIA INTERNATIONALIS
2017
Biomarkers in head and neck cancer : looking through and beyond the microscope
Astrid De Meulenaere
Sylvie Rottey
Liesbeth Ferdinande
Dissertation
2017
CD70 and PD-L1 in anaplastic thyroid cancer : promising targets for immunotherapy
Karen Zwaenepoel
Julie Jacobs
Astrid De Meulenaere
Karen Silence
Evelien Smits
Vasiliki Siozopoulou
Esther Hauben
Christian Rolfo
Sylvie Rottey
Patrick Pauwels
A1
Journal Article
in
HISTOPATHOLOGY
2017
Checkpoint inhibition : new treatment options in urologic cancer
Daan De Maeseneer
Brant Delafontaine
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2017
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial
Katrien De Wolf
Sylvie Rottey
Karim Vermaelen
Karel Decaestecker
Nora Sundahl
Lizzy De Lobel
Els Goetghebeur
Gert De Meerleer
Nicolaas Lumen
Valerie Fonteyne
et al.
A1
Journal Article
in
RADIATION ONCOLOGY
2017
Congress highlights : ESMO 2017 special edition : highlights in genitourinary cancers
Tijl Vermassen
Sylvie Rottey
Other
2017
Distant metastases in head and neck cancer
Fréderic Duprez
Dieter Berwouts
Wilfried De Neve
Katrien Bonte
Tom Boterberg
Philippe Deron
Wouter Huvenne
Sylvie Rottey
Marcus Mareel
A1
Journal Article
in
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
2017
Evaluation of novel treatments in prostate cancer : concerning innovations in the field of minimal-invasive surgery, whole-pelvis radiotherapy and hormonal therapy with abiraterone acetate
Charles Van Praet
Nicolaas Lumen
Sylvie Rottey
Dissertation
2017
Highlights in genitourinary cancers from the 2017 ASCO Genitourinary Cancers Symposium
Tijl Vermassen
Sylvie Rottey
Report
2017
How far to investigate presumed psychosomatic symptoms : lessons from a particular case…
Marie-Angélique De Scheerder
Sylvie Rottey
An Mariman
Marleen Praet
Dirk Vogelaers
A1
Journal Article
in
ACTA CLINICA BELGICA
2017
Impact of haptoglobine polymorphism on survival of renal cell carcinoma patients
Tijl Vermassen
Nicolaas Lumen
Joris Delanghe
Sylvie Rottey
C3
Conference
2017
Metastatic burden in newly diagnosed hormone-naive metastatic prostate cancer : comparing the definitions of CHAARTED and LATITUDE trial
Sarah Buelens
Karel Decaestecker
Valerie Fonteyne
Piet Ost
Sofie Verbeke
Geert Villeirs
Sylvie Rottey
Nicolaas Lumen
C3
Conference
2017
Phase I dose-escalation study of the anti-CD70 antibody ARGX-110 in advanced malignancies
Philippe Aftimos
Christian Rolfo
Sylvie Rottey
Fritz Offner
Dominique Bron
Marie Maerevoet
Jean-Charles Soria
Mahan Moshir
Torsten Dreier
Luc Van Rompaey
et al.
A1
Journal Article
in
CLINICAL CANCER RESEARCH
2017
Phenotyping of the immune infiltrate in oropharyngeal squamous cell carcinoma : focus on materials and methods
Astrid De Meulenaere
Tijl Vermassen
Sylvie Rottey
Liesbeth Ferdinande
C3
Conference
2017
Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy
Julie Jacobs
Vanessa Deschoolmeester
Christian Rolfo
Karen Zwaenepoel
Jolien Van den Bossche
Christophe Deben
Karen Silence
Hans de Haard
Christophe Hermans
Sylvie Rottey
et al.
A1
Journal Article
in
ONCOTARGET
2017
Prognostic markers in oropharyngeal squamous cell carcinoma : focus on CD70 and tumour infiltrating lymphocytes
Astrid De Meulenaere
Tijl Vermassen
Sandrine Aspeslagh
Karen Zwaenepoel
Philippe Deron
Fréderic Duprez
Sylvie Rottey
Liesbeth Ferdinande
A1
Journal Article
in
PATHOLOGY
2017
Prostaatkanker en de rol van de huisarts
Marco Blanker
Kristel van Asselt
Sylvie Rottey
Daan De Maeseneer
Filip Poelaert
Bookchapter
in
Oncologie
2017
Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile
Tijl Vermassen
Katharina D'Herde
Dominique Jacobus
Charles Van Praet
Filip Poelaert
Nicolaas Lumen
Nico Callewaert
Karel Decaestecker
Geert Villeirs
Piet Hoebeke
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL PATHOLOGY
2017
The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma : prognostic features in the era of targeted therapies
Tom Claeys
Nicolaas Lumen
Candy Kumps
Marleen Praet
Gert De Meerleer
Sylvie Rottey
Piet Ost
Pieter De Visschere
Geert Villeirs
Valerie Fonteyne
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2017
TILs in head and neck cancer : ready for clinical implementation and why (not)?
Astrid De Meulenaere
Tijl Vermassen
SANDRINE ASPESLAGH
Katrien Vandecasteele
Sylvie Rottey
Liesbeth Ferdinande
A2
Journal Article
in
HEAD & NECK PATHOLOGY
2017
Tumor PD-L1 status and CD8+ tumor-infiltrating T cells : markers of improved prognosis in oropharyngeal cancer
Astrid De Meulenaere
Tijl Vermassen
SANDRINE ASPESLAGH
Philippe Deron
Fréderic Duprez
Debby Laukens
Jo Van Dorpe
Liesbeth Ferdinande
Sylvie Rottey
A1
Journal Article
in
ONCOTARGET
2017
Turning the tide : clinical utility of PD-L1 expression in squamous cell carcinoma of the head and neck
Astrid De Meulenaere
Tijl Vermassen
SANDRINE ASPESLAGH
Wouter Huvenne
Jo Van Dorpe
Liesbeth Ferdinande
Sylvie Rottey
A1
Journal Article
in
ORAL ONCOLOGY
2017
Which factors predict overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post-docetaxel?
Charles Van Praet
Sylvie Rottey
Fransien Van Hende
Gino Pelgrims
Wim Demey
Filip Van Aelst
Wim Wynendaele
Thierry Gil
Peter Schatteman
Bertrand Filleul
et al.
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2017
2016
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function
Analía Azaro
Jordi Rodón
Jean-Pascal Machiels
Sylvie Rottey
Silvia Damian
Richard Baird
Javier Garcia-Corbacho
Ron HJ Mathijssen
Pierre-François Clot
Claudine Wack
et al.
A1
Journal Article
in
CANCER CHEMOTHERAPY AND PHARMACOLOGY
2016
A phase I study in T cell lymphoma patients treated with anti-CD70 simple antibody (TM) ARGX-110
JM Michot
M Maerevoet
P Aftimos
Sylvie Rottey
C Rolfo
Fritz Offner
L Van Rompaey
M Moshir
H de Haard
K Silence
et al.
C3
Conference
2016
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program
Charles Van Praet
Sylvie Rottey
Fransien Van Hende
Gino Pelgrims
Wim Demey
Filip Van Aelst
Wim Wynendaele
Thierry Gil
Peter Schatteman
Bertrand Filleul
et al.
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2016
CD70 Expression and its correlation with clinicopathological variables in squamous cell carcinoma of the head and neck
Astrid De Meulenaere
Tijl Vermassen
Sandrine Aspeslagh
Karen Zwaenepoel
Philippe Deron
Fréderic Duprez
Liesbeth Ferdinande
Sylvie Rottey
A1
Journal Article
in
PATHOBIOLOGY
2016
Clinical response observed in a phase I study in T cell lymphoma patients treated with anti-CD70 SIMPLE antibody ARGX-110
Jean-Marie Michot
Marie Maerevoet
Philippe Georges Aftimos
Sylvie Rottey
Christian Diego Rolfo
Fritz Offner
Luc Van Rompaey
Mahan Moshir
Hans de Haard
Karen Silence
et al.
C3
Conference
2016
Congress highlights : ASCO 2016 special edition : highlights in genitourinary cancers
Tijl Vermassen
Sylvie Rottey
Other
2016
Congress highlights : ESMO 2016 special edition : highlights in genitourinary cancers
Tijl Vermassen
Sylvie Rottey
Other
2016
Effect of itraconazole and rifampin on the pharmacokinetics of olaparib in patients with advanced solid tumors : results of two phase I open-label studies
Luc Dirix
Helen Swaisland
Henk MW Verheul
Sylvie Rottey
Karin Leunen
Guy Jerusalem
Christian Rolfo
Dorte Nielsen
L Rhoda Molife
Rebecca Kristeleit
et al.
A1
Journal Article
in
CLINICAL THERAPEUTICS
2016
Glycosylation of urinary prostate proteins and its potential diagnostic applications
Tijl Vermassen
Sylvie Rottey
Joris Delanghe
Dissertation
2016
Phase I study of mTORC1/2 inhibitor BI 860585 as single agent or with exemestane or paclitaxel in patients with advanced solid tumors
Filippo G De Braud
Jean-Pascal H Machiels
Marcello Tiseo
Sylvie Rottey
Matteo Duca
Marie Laruelle
Stefania Salvagni
Lore Lapeire
Laura Manfreda
Celine Veau
et al.
C3
Conference
2016
Phase I study of ribociclib plus cetuximab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
E Seront
S Schmitz
Sylvie Rottey
S Henry
C Lonchay
G van Caloen
A Gilain
J-P Machiels
C3
Conference
2016
Phase II study of dual phosphoinositol-3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor BEZ235 in patients with locally advanced or metastatic transitional cell carcinoma
Emmanuel Seront
Sylvie Rottey
Bertrand Filleul
Philippe Glorieux
Jean-Charles Goeminne
Vincent Verschaeve
Jean-Marie Vandenbulcke
Brieuc Sautois
Petra Boegner
Aline Gillain
et al.
A1
Journal Article
in
BJU INTERNATIONAL
2016
Randomized phase II study of cabazitaxel versus methotrexate in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based therapy
Jean-Pascal Henry Machiels
Aline Van Maanen
Jean-Marie Vandenbulcke
Bertrand Filleul
Emmanuel Seront
Stéphanie Henry
Lionel D'Hondt
Christophe Lonchay
Stéphane Holbrechts
Petra Boegner
et al.
A1
Journal Article
in
ONCOLOGIST
2016
Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma
Tijl Vermassen
Astrid De Meulenaere
M. Van de Walle
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2016
Third Belgian multidisciplinary meeting on urological cancers
Tijl Vermassen
Ronald De Wit
Roland Van Velthoven
Simone Albisinni
Nieves Martinez Chanza
Fouad Youssef Aoun
Emmanuel Seront
Sylvie Rottey
Other
2016
Virussen in de behandeling van kanker : oncolytische virotherapie
Brant Delafontaine
Griet Van Lancker
Lucas Van Bortel
Sylvie Rottey
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2016
2015
A phase I study of volasertib combined with afatinib, in advanced solid tumors
Jean-Pascal Machiels
Marc Peeters
Catherine Herremans
Veerle Surmont
Pol Specenier
Marina De Smet
Korinna Pilz
Natalja Strelkowa
Dan Liu
Sylvie Rottey
A1
Journal Article
in
CANCER CHEMOTHERAPY AND PHARMACOLOGY
2015
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) : final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Charles J Ryan
Matthew R Smith
Karim Fizazi
Fred Saad
Peter F A Mulders
Cora N Sternberg
Kurt Miller
Christopher J Logothetis
Neal D Shore
Eric J Small
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2015
Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1) : an open-label, randomised phase 3 trial
Jean-Pascal H Machiels
Robert I Haddad
Jérôme Fayette
Lisa F Licitra
Makoto Tahara
Jan B Vermorken
Paul M Clement
Thomas Gauler
Didier Cupissol
Juan José Grau
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2015
Battling resistance mechanisms in antihormonal prostate cancer treatment: novel agents and combinations
Daan Joost De Maeseneer
Charles Van Praet
Nicolaas Lumen
Sylvie Rottey
A1
Journal Article
in
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
2015
Biomarker analysis in a phase II study of sunitinib in patients with advanced melanoma
L Decoster
I Vande Broek
B Neyns
F Majois
JF Baurain
Sylvie Rottey
A Rorive
E Anckaert
J De Mey
S De Brakeleer
et al.
A1
Journal Article
in
ANTICANCER RESEARCH
2015
CD70 : an emerging target in cancer immunotherapy
J. Jacobs
V. Deschoolmeester
K. Zwaenepoel
C. Rolfo
K. Silence
Sylvie Rottey
F. Lardon
E. Smits
P. Pauwels
A1
Journal Article
in
PHARMACOLOGY & THERAPEUTICS
2015
Congress highlights: ASCO 2015 special edition: highlights in genitourinary cancers from the 2015 ASCO annual meeting
Tijl Vermassen
Sylvie Rottey
Editorial material
2015
Congress highlights: ECCO-ESMO 2015 special edition: highlights in genitourinary cancers from the 18th ECCO – 40th ESMO European cancer congress
Tijl Vermassen
Sylvie Rottey
Editorial material
2015
Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis
Tijl Vermassen
Charles Van Praet
Filip Poelaert
Nicolaas Lumen
Karel Decaestecker
Piet Hoebeke
Simon Van Belle
Sylvie Rottey
Joris Delanghe
A1
Journal Article
in
BIOCHEMIA MEDICA
2015
Evaluation of abiraterone acetate post-docetaxel in the Belgian compassionate use program
Sylvie Rottey
Charles Van Praet
Fransien Van Hende
Gino Pelgrims
Wim Demey
Filip Van Aelst
Wim Wynendaele
Thierry Gil
Peter Schatteman
Bertrand Filleul
et al.
C3
Conference
2015
Evaluation of the effect of cytoreductive nephrectomy on the course of metastatic renal cell carcinoma: a single centre study
Tom Claeys
Nicolaas Lumen
Gilles Thuysbaert
Marleen Praet
Gert De Meerleer
Sylvie Rottey
Piet Ost
Pieter De Visschere
Geert Villeirs
Valérie Fonteyne
et al.
C3
Conference
2015
G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy
Lies Pottel
Michelle Lycke
Tom Boterberg
Hans Pottel
Laurence Goethals
Fréderic Duprez
Sylvie Rottey
Yolande Lievens
Nele Van Den Noortgate
Kurt Geldhof
et al.
A1
Journal Article
in
BMC CANCER
2015
Immunohistochemical analysis of CD70 expression in 95 cases of squamous cell carcinoma of the head and neck: correlation with clinicopathological variables and identification of a novel therapeutic target
Astrid De Meulenaere
Tijl Vermassen
S Aspeslagh
Philippe Deron
Fréderic Duprez
K Silence
J Jacobs
K Zwaenepoel
P Pauwels
Sylvie Rottey
et al.
C3
Conference
2015
Necrotizing myopathy as a paraneoplastic syndrome associated with renal cell carcinoma
Eline Naert
Jan De Bleecker
Nicolaas Lumen
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2015
Nivolumab versus everolimus in advanced renal-cell carcinoma
Robert J. Motzer
Bernard Escudier
David F. McDermott
Saby George
Hans J. Hammers
Sandhya Srinivas
Scott S. Tykodi
Jeffrey A. Sosman
Giuseppe Procopio
Elizabeth R. Plimack
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2015
Oncogenetic testing, diagnosis and follow-up in Birt-Hogg-Dubé syndrome, familial atypical multiple mole melanoma syndrome and neurofibromatosis 1 and 2
Jo Robays
Sabine Stordeur
Frank Hulstaert
Jean-François Baurain
Lieve Brochez
Teofila Caplanusi
Kathleen Claes
Eric Legius
Sylvie Rottey
Dirk Schrijvers
et al.
Report
2015
Prolonged survival in a nasopharyngeal carcinoma (NPC) patient with metastatic disease : a case report
Astrid De Meulenaere
Philippe Deron
Fréderic Duprez
Liesbeth Ferdinande
Luc Verbeke
M De Vuyst
Sylvie Rottey
A2
Journal Article
in
AUSTIN JOURNAL OF OTOLARYNGOLOGY
2015
REACT expanded-access program in patients with metastatic renal cell carcinoma : real-world data from a European subanalysis
S Bracarda
Sylvie Rottey
A Bahl
C Eichelberg
B Mellado
L Mangel
A Cattaneo
A Panneerselvam
V Grunwald
A1
Journal Article
in
FUTURE ONCOLOGY
2015
Second Belgian multidisciplinary meeting on urological cancers held in Brussels, March 28th, 2015
Tijl Vermassen
Pieter De Visschere
Geert Villeirs
D Schrijvers
Sylvie Rottey
Editorial material
2015
Urinary prostate protein glycosylation profiling as a diagnostic biomarker for prostate cancer
Tijl Vermassen
Charles Van Praet
Nicolaas Lumen
Karel Decaestecker
Dieter Vanderschaeghe
Nico Callewaert
Geert Villeirs
Piet Hoebeke
Simon Van Belle
Sylvie Rottey
et al.
A1
Journal Article
in
PROSTATE
2015
2014
A first-in-class, first-in-human phase I study of enadenotucirev, an oncolytic Ad11/Ad3 chimeric group B adenovirus, administered intravenously in patients with metastatic epithelial tumors
Emiliano Calvo
Marta Gil-Martin
Jean-Pascal Machiels
Sylvie Rottey
Antonio Cubillo
Ramon Salazar
Feby Ingriani Mardjuadi
Karen Geboes
Christopher Ellis
John William Beadle
et al.
C3
Conference
2014
A phase 1 study of enadenotucirev, an oncolytic AD11/AD3 chimeric group B adenovirus, administered intravenously : analysis of dose expansion and repeat cycle cohorts in patients with metastatic colorectal cancer (MCRC)
E. Calvo
M. Gil Martin
A. Cubillo
J. Machiels
Sylvie Rottey
F. Mardjuadi
Karen Geboes
R. Salazar
J. Beadle
C. Ellis
et al.
C3
Conference
2014
Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring?
Charles Van Praet
Louis Libbrecht
Frederik D'Hont
Karel Decaestecker
Valérie Fonteyne
Stephanie VERSCHUERE
Sylvie Rottey
Marleen Praet
Pieter De Visschere
Nicolaas Lumen
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2014
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
Pierre Maison-Blanche
Shaker Dakhil
Ari Baron
Sylvie Rottey
Fred Millard
Gedske Daugaard
Jean-Pascal Machiels
William Conkright
Sunil Sharma
Patricia MMB Soetekouw
et al.
A1
Journal Article
in
CANCER CHEMOTHERAPY AND PHARMACOLOGY
2014
Capillary electrophoresis of urinary prostate glycoproteins assists in the diagnosis of prostate cancer
Tijl Vermassen
Charles Van Praet
Dieter Vanderschaeghe
Thomas Maenhout
Nicolaas Lumen
Nico Callewaert
Piet Hoebeke
Simon Van Belle
Sylvie Rottey
Joris Delanghe
A1
Journal Article
in
ELECTROPHORESIS
2014
Chromosome X polysomy is associated with increased androgen receptor expression in epithelial cells and reduced expression in stromal cells in treatment-naive prostate cancer
Charles Van Praet
Filip Poelaert
Stephanie VERSCHUERE
Louis Libbrecht
Marleen Praet
Sylvie Rottey
Simon Van Belle
Karel Decaestecker
Tom Claeys
Nicolaas Lumen
C3
Conference
2014
Congress highlights: ESMO 2014 special edition: highlights in genitourinary cancer
Tijl Vermassen
Sylvie Rottey
Editorial material
2014
Congress highlights: first Belgian multidisciplinary meeting on urological cancers held in Brussels, March 29th 2014
Tijl Vermassen
Jan Martijn Kerst
Bertrand Tombal
Sylvie Rottey
Editorial material
2014
Contemporary minimally-invasive extended pelvic lymph node dissection for prostate cancer before curative radiotherapy: prospective standardized analysis of complications
Charles Van Praet
Karel Decaestecker
Valérie Fonteyne
Piet Ost
Pieter De Visschere
Stephanie VERSCHUERE
Sylvie Rottey
Nicolaas Lumen
A1
Journal Article
in
INTERNATIONAL JOURNAL OF UROLOGY
2014
Echium oil is not protective against weight loss in head and neck cancer patients undergoing curative radio(chemo)therapy: a randomised-controlled trial
Lies Pottel
Michelle Lycke
Tom Boterberg
Hans Pottel
Laurence Goethals
Fréderic Duprez
Alex Maes
Stefan Goemaere
Sylvie Rottey
Imogen Foubert
et al.
A1
Journal Article
in
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE
2014
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)
A. Ruzsa
M. Sen
M. Evans
L. W. Lee
K. Hideghety
Sylvie Rottey
P. Klimak
P. Holeckova
J. Fayette
T. Csoszi
et al.
A1
Journal Article
in
INVESTIGATIONAL NEW DRUGS
2014
Possible use of urinary prostate proteins glycosylation profile as a diagnostic biomarker for prostate cancer
Tijl Vermassen
Nicolaas Lumen
Charles Van Praet
Dieter Vanderschaeghe
Nico Callewaert
Piet Hoebeke
Simon Van Belle
Joris Delanghe
Sylvie Rottey
C3
Conference
2014
Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium
NATASHA CORNELIS
Tijl Vermassen
D Schallier
J-P Machiels
T Gil
PR Debruyne
R D'hondt
A Bols
D Schrijvers
J Mebis
et al.
A1
Journal Article
in
ACTA CLINICA BELGICA
2014
Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life
Lies Pottel
Michelle Lycke
Tom Boterberg
Hans Pottel
Laurence Goethals
Fréderic Duprez
Nele Van Den Noortgate
Wilfried De Neve
Sylvie Rottey
Kurt Geldhof
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER CARE
2014
Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug-drug interactions
VIBEKE KRUSE
Annemie Somers
Lucas Van Bortel
ANNELEEN DE BOTH
Simon Van Belle
Sylvie Rottey
A1
Journal Article
in
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
2014
2013
A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors
JB Vermorken
Sylvie Rottey
E Ehrnrooth
K Pelling
A Lahogue
S Wind
J-P Machiels
A1
Journal Article
in
ANNALS OF ONCOLOGY
2013
A randomized, double-blind, placebo-controlled study to assess QTc interval prolongation of standard dose aflibercept in cancer patients treated with docetaxel
Pierre Maison-Blanche
Jan B. Vermorken
Tuncay Goksel
Jean-Pascal Machiels
Sanjiv Agarwala
Sylvie Rottey
Gedske Daugaard
Constantin Volovat
Max Scheulen
Lisa Sengeløv
et al.
A1
Journal Article
in
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
2013
Abiraterone in metastatic prostate cancer without previous chemotherapy
Charles J. Ryan
Matthew R. Smith
Johann S. de Bono
Arturo Molina
Christopher J. Logothetis
Paul de Souza
Karim Fizazi
Paul Mainwaring
Josep M. Piulats
Siobhan Ng
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2013
Attacking the androgen receptor pathway in prostate cancer
Charles Van Praet
Daan De Maeseneer
Nicolaas Lumen
Sylvie Rottey
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2013
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B Vermorken
Jan Stoelmacher-Williams
Irina Davidenko
Lisa Licitra
Eric Winquist
Cristian Villanueva
Paolo Foa
Sylvie Rottey
Krzysztof Skladowski
Makoto Tahara
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2013
Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy
Stephen Harland
John Staffurth
Arturo Molina
Yanni Hao
Dennis D. Gagnon
Cora N. Sternberg
David Cella
Karim Fizazi
Christopher J. Logothetis
Thian Kheoh
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2013
Prostate proteins glycosylation profile and its potential as a diagnostic biomarker for prostate cancer
Tijl Vermassen
Nicolaas Lumen
Charles Van Praet
Dieter Vanderschaeghe
Nico Callewaert
Piet Hoebeke
Simon Van Belle
Sylvie Rottey
Joris Delanghe
C1
Conference
2013
Retrospective analysis of metastatic renal cell cancer patients treated with sunitinib and the role of possible interactions
VIBEKE KRUSE
A De Both
N Beck
Lucas Van Bortel
Simon Van Belle
Sylvie Rottey
C3
Conference
2013
Serial Comprehensive Geriatric Assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life
Lies Pottel
Michelle Lycke
Tom Boterberg
Hans Pottel
Laurence Goethals
Fréderic Duprez
Nele Van Den Noortgate
Wilfried De Neve
Sylvie Rottey
Kurt Geldhof
et al.
C3
Conference
2013
2012
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer : final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi
Howard I Scher
Arturo Molina
Christopher J Logothetis
Kim N Chi
Robert J Jones
John N Staffurth
Scott North
Nicholas J Vogelzang
Fred Saad
et al.
A1
Journal Article
in
LANCET ONCOLOGY
2012
An international expanded-access programme of everolimus : addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy
Viktor Grünwald
Pierre I. Karakiewicz
Sevil E. Bavbek
Kurt Miller
Jean-Pascal Machiels
Se-Hoon Lee
James Larkin
Petri Bono
Sun Young Rha
Daniel Castellano
et al.
A1
Journal Article
in
EUROPEAN JOURNAL OF CANCER
2012
Androgen receptor gene amplification in primary prostate cancer patients
Charles Van Praet
Louis Libbrecht
Sylvie Rottey
Marleen Praet
Simon Van Belle
Nicolaas Lumen
C3
Conference
2012
Blaasconserverende behandelingen voor invasieve blaaskanker: een te weinig gebruikte mogelijkheid
Karel Decaestecker
Gert De Meerleer
Sylvie Rottey
Nicolaas Lumen
Valérie Fonteyne
Willem Oosterlinck
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2012
Compliance with sunitinib treatment in patients with renal cell cancer
ANNELEEN DE BOTH
VIBEKE KRUSE
Elise De Coene
NELE CLOTTENS
Annemie Somers
Simon Van Belle
Lucas Van Bortel
Sylvie Rottey
C3
Conference
2012
De plaats van cetuximab in de behandeling van hoofd- en halstumoren
Lore Lapeire
Philippe Deron
Fréderic Duprez
Sylvie Rottey
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2012
Determination of an adequate screening tool for identification of vulnerable elderly head and neck cancer patients treated with radio(chemo)therapy
Lies Pottel
Tom Boterberg
Hans Pottel
Laurence Goethals
Nele Van Den Noortgate
Fréderic Duprez
Wilfried De Neve
Sylvie Rottey
Kurt Geldhof
Koen Van Eygen
et al.
A1
Journal Article
in
JOURNAL OF GERIATRIC ONCOLOGY
2012
Experience with Lexicomp® Online Drug Database for medication review and drug-drug interaction analysis within a comprehensive geriatric assessment in elderly cancer patients
Lies Pottel
Michelle Lycke
Tom Boterberg
Lore Ketelaars
Hans Pottel
Laurence Goethals
Nele Van Den Noortgate
Fréderic Duprez
Wilfried De Neve
Sylvie Rottey
et al.
A2
Journal Article
in
JOURNAL OF ANALYTICAL ONCOLOGY
2012
Experience with Lexicomp® online drug database for medication review and drug-drug interaction analysis within comprehensive geriatric assessment in elderly cancer patients
Michelle Lycke
Lies Pottel
Tom Boterberg
Hans Pottel
Laurence Goethals
Nele Van Den Noortgate
Fréderic Duprez
Wilfried De Neve
Sylvie Rottey
Kurt Geldhof
et al.
C3
Conference
2012
Glycosylation of prostate specific antigen and its potential diagnostic applications
Tijl Vermassen
Marijn Speeckaert
Nicolaas Lumen
Sylvie Rottey
Joris Delanghe
A1
Journal Article
in
CLINICA CHIMICA ACTA
2012
International, expanded-access programme of everolimus in patients with metastatic renal cell carcinoma who progressed after prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: sub-analysis of European patients
S Bracarda
Sylvie Rottey
A Bahl
C Eichelberg
B Mellado
L Mangel
J Mardiak
I Bouzaklas
A Panneerselvam
V Grunwald
C3
Conference
2012
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers
E Seront
Sylvie Rottey
B Sautois
J Kerger
LA D'Hondt
V Verschaeve
J-L Canon
C Dopchie
JM Vandenbulcke
N Whenham
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2012
Serial comprehensive geriatric evaluation in elderly head and neck cancer patients undergoing radiotherapy
Philip R Debruyne
Michelle Lycke
Tom Boterberg
Hans Pottel
Laurence Goethals
Nele Van Den Noortgate
Fréderic Duprez
Sylvie Rottey
Khalil Kargar-Samani
Lies Pottel
C3
Conference
2012
Serial comprehensive geriatric evaluation in elderly head and neck cancer patients undergoing radiotherapy
PR Debruyne
M Lycke
Tom Boterberg
H Pottel
L Goethals
Nele Van Den Noortgate
Fréderic Duprez
Sylvie Rottey
K Kargar-Samani
L Pottel
C3
Conference
2012
Serial comprehensive geriatric evaluation in older head and neck cancer patients undergoing radiotherapy
Lies Pottel
Michelle Lycke
Tom Boterberg
Hans Pottel
Laurence Goethals
Lore Ketelaars
Nele Van Den Noortgate
Fréderic Duprez
Wilfried De Neve
Sylvie Rottey
et al.
C3
Conference
2012
2011
'Doe-het-zelf chemotherapie advies' : gevaarlijke ontwikkelingen via het worldwide web
Karen Geboes
Sylvie Rottey
Stéphanie Laurent
Johan Vandenbroucke
Marc Peeters
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2011
A phase Ib open-label study to assess continuous oral treatment with afatinib (BIBW 2992) in combination with two chemotherapy regimens: cisplatin plus paclitaxel, and cisplatin plus 5-fluorouracil in patients, with advanced solid tumours
J Vermorken
Sylvie Rottey
E Ehrnrooth
K Pelling
A Lahogue
J Machiels
C3
Conference
2011
Abiraterone and increased survival in metastatic prostate cancer
Johann S. de Bono
Christopher J. Logothetis
Arturo Molina
Karim Fizazi
Scott North
Luis Chu
Kim N. Chi
Robert J. Jones
Oscar B. Goodman
Fred Saad
et al.
A1
Journal Article
in
NEW ENGLAND JOURNAL OF MEDICINE
2011
Angiogenesis-related cytokines as potential predictive biomarkers in a phase II trial evaluating everolimus efficacy in locally advanced or metastatic transitional carcinoma cell
E Seront
Sylvie Rottey
B Sautois
L Dhondt
J-L Canon
J-M Vandenbulcke
N Whenham
J-C Goeminne
O Feron
J-P Machiels
C3
Conference
2011
Cardiovascular toxicity of cancer treatment
MATTHIEU COMBES
Sylvie Rottey
Tine De Backer
A1
Journal Article
in
ACTA CLINICA BELGICA
2011
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study
L Licitra
R Mesia
F Rivera
É Remenár
R Hitt
J Erfán
Sylvie Rottey
A Kawecki
D Zabolotnyy
M Benasso
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2011
High dose chemotherapy and stem cell rescue for metastatic germ cell tumours: long term results from a single institution
VIBEKE KRUSE
Lucien Noens
Nicolaas Lumen
Piet Hoebeke
Simon Van Belle
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2011
Metabolic tumour volume : prognostic value in locally advanced squamous cell carcinoma of the head and neck
Philippe Deron
Koen Mertens
Ingeborg Goethals
Sylvie Rottey
Fréderic Duprez
Wilfried De Neve
Hubert Vermeersch
Christophe Van De Wiele
A1
Journal Article
in
NUKLEARMEDIZIN-NUCLEAR MEDICINE
2011
Modern treatment for nasopharyngeal carcinoma : current status and prospects
Sylvie Rottey
Indira Madani
Philippe Deron
Simon Van Belle
A1
Journal Article
in
CURRENT OPINION IN ONCOLOGY
2011
Nephrotoxicity of anticancer drugs: an underestimated problem?
Norbert Lameire
VIBEKE KRUSE
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2011
PARP inhibitors in oncology: a new synthetic lethal approach to cancer therapy
VIBEKE KRUSE
Sylvie Rottey
Ole De Backer
Simon Van Belle
Veronique Cocquyt
Hannelore Denys
A1
Journal Article
in
ACTA CLINICA BELGICA
2011
2010
18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours
Daan De Maeseneer
Bieke Lambert
Veerle Surmont
Karen Geboes
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2010
Cardiac toxicity of trastuzumab : experience at the Ghent University Hospital, Belgium
CAROLINE LAMOT
Sylvie Rottey
Tine De Backer
Lucas Van Bortel
Hugo Robays
Simon Van Belle
Hannelore Denys
Veronique Cocquyt
A1
Journal Article
in
ACTA CLINICA BELGICA
2010
Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
TE Hutson
ID Davis
JPH Machiels
PL De Souza
Sylvie Rottey
BF Hong
RJ Epstein
KL Baker
L McCann
T Crofts
et al.
A1
Journal Article
in
JOURNAL OF CLINICAL ONCOLOGY
2010
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck
R Mesía
F Rivera
A Kawecki
Sylvie Rottey
R Hitt
H Kienzer
D Cupissol
D De Raucourt
M Benasso
P Koralewski
et al.
A1
Journal Article
in
ANNALS OF ONCOLOGY
2010
Targeted therapy for metastatic renal cell cancer
CAROLINE VERBAEYS
Piet Hoebeke
Simon Van Belle
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2010
2009
A RARE INFECTIOUS COMPLICATION AFTER ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION IN AN ONCOLOGICAL PATIENT AND REVIEW OF THE LITERATURE
FRANK VAN FRAEYENHOVE
CAROLINE LAMOT
Dirk Vogelaers
Simon Van Belle
Ercan Cesmeli
Sylvie Rottey
A1
Journal Article
in
Acta Clinica Belgica
2009
Complicaties van oncologische therapie thuis opvangen
Sylvie Rottey
Lucas Van Bortel
Simon Van Belle
A2
Journal Article
in
Tijdschrift voor Geneeskunde
2009
Influence of chemotherapy on the biodistribution of [99mTc]hydrazinonicotinamide annexin V in cancer patients
Sylvie Rottey
BIEKE VAN DEN BOSSCHE
G Slegers
Simon Van Belle
Christophe Van De Wiele
A1
Journal Article
in
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2009
Mitoxantronchemotherapie voor de behandeling van multiple sclerose
Lore Lapeire
Jan Debruyne
Sylvie Rottey
A2
Journal Article
in
TIJDSCHRIFT VOOR GENEESKUNDE
2009
Trombotische microangiopathie als eerste teken van gemetastaseerd borstcarcinoom
Wouter De Corte
Sylvie Rottey
Pieter Depuydt
JOKE NOLLET
J. Phillipé
Dominique Benoit
A2
Journal Article
in
Tijdschrift voor Geneeskunde
2009
Verwikkelingen van oncologische therapie thuis opvangen
Sylvie Rottey
Lucas Van Bortel
Simon Van Belle
A2
Journal Article
in
Tijdschrift voor geneeskunde
2009
2008
F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma - A case report
Piet Ost
Sylvie Rottey
Peter Smeets
Tom Boterberg
Barbara Stragier
Ingeborg Goethals
A1
Journal Article
in
Journal of Thoracic Imaging
2008
OSTEOSARCOMA WITH EXTENSIVE CALCIFIED PLEURAL METASTASES AT DIAGNOSIS
NATACHA VERBEKE
Koenraad Verstraete
Gwen Sys
Ramses Forsyth
D. Kluyskens
Hannelore Denys
Dirk Uyttendaele
Sylvie Rottey
A1
Journal Article
in
Acta Clinica Belgica
2008
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan Vermorken
Ricard Mesia
Fernando Rivera
Eva Remenar
Andrzej Kawecki
Sylvie Rottey
Jozsef Erfan
Dmytro Zabolotnyy
Heinz-Roland Kienzer
Didier Cupissol
et al.
A1
Journal Article
in
New England Journal of Medicine
2008
2007
(99m)Tc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy
Sylvie Rottey
D LOOSE
Luc Vakaet
C LAHORTE
Hubert Vermeersch
Simon Van Belle
Christophe Van De Wiele
A2
Journal Article
in
Q J Nucl Med Mol Imaging
2007
99m TC-HYNIC Annexin-V for monitoring response to chemotherapy : methodology and feasibility studies
Sylvie Rottey
Simon Van Belle
Christophe Van De Wiele
Dissertation
2007
A Belgian registry of interleukin-2 administration for treatment of metastatic renal cell cancer and confrontation with literature data
Inneke Bambust
F. Van Aelst
E. Joosens
D. Schallier
H. Kalantari
R. Paulus
Vincent Renard
M. Clausse
L. Duck
S. Luce
et al.
A1
Journal Article
in
ACTA CLINICA BELGICA
2007
One-stage penectomy and phalloplasty for epithelioid sarcoma of the penis in an adolescent
Piet Hoebeke
Sylvie Rottey
Nathalie Van Heddeghem
Geert Villeirs
Patrick Pauwels
WILLY SCHRAUWEN
Peter Ceulemans
Stan Monstrey
A1
Journal Article
in
EUROPEAN UROLOGY
2007
One-stage penectomy and phalloplasty for epithelioid sarcoma of the penis in an adolescent, part 2
Piet Hoebeke
Sylvie Rottey
Nathalie Van Heddeghem
Geert Villeirs
PASCALE PAUWELS
WILLY SCHRAUWEN
Peter Ceulemans
Stan Monstrey
A1
Journal Article
in
EUROPEAN UROLOGY
2007
Radiolabelled chemotherapeutics
Sylvie Rottey
A SIGNORE
Christophe Van De Wiele
A1
Journal Article
in
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2007
Tc-99m-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy
Sylvie Rottey
David Loose
Luc Vakaet
C LAHORTE
Hubert Vermeersch
Simon Van Belle
Christophe Van De Wiele
A1
Journal Article
in
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2007
2006
Cyclooxygenase-2 as a target for anticancer drug development
Jean-Baptiste Méric
Sylvie Rottey
Ken Olaussen
Jean-Charles Soria
David Khayat
Olivier Rixe
Jean-Philippe Spano
A1
Journal Article
in
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2006
Evaluation of metastatic lymph nodes in head and neck cancer: A comparative study between palpation, ultrasonography, ultrasound-guided fine needle aspiration cytology and computed tomography
Sylvie Rottey
Mirko Petrovic
WOUTER BAUTERS
Kris Mervillie
ELS VANHERREWEGHE
Katrien Bonte
Simon Van Belle
Hubert Vermeersch
A1
Journal Article
in
ACTA CLINICA BELGICA
2006
Sequential Tc-99m-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy
Sylvie Rottey
Guido Slegers
Simon Van Belle
Ingeborg Goethals
Christophe Van De Wiele
A1
Journal Article
in
JOURNAL OF NUCLEAR MEDICINE
2006
2005
Phenytoin intoxication in critically ill patients
Gert De Schoenmakere
Jan De Waele
Wim Terryn
Mieke Deweweire
Alain Verstraete
Eric Hoste
Sylvie Rottey
Norbert Lameire
Francis Colardyn
A1
Journal Article
in
AMERICAN JOURNAL OF KIDNEY DISEASES
2005
2004
Intraobserver, interobserver, and day-to-day reproducibility of quantitative Tc-99m-HYNIC annexin-V imaging in head and neck carcinoma
Hubert Vermeersch
Hamphrey Ham
Sylvie Rottey
C LAHORTE
F CORSETTI
Rudi Dierckx
N STEINMETZ
Christophe Van De Wiele
A1
Journal Article
in
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
2004
2003
99(m)Tc sestamibi and Tc-99m tetrofosmin scintigraphy for predicting resistance to chemotherapy: a critical review of clinical data
Christophe Van De Wiele
Sylvie Rottey
Ingeborg Goethals
J BUSCOMBE
Simon Van Belle
FILIP DE VOS
Rudi Dierckx
Editorial material
2003
99mTc sestamibi and 99mTc tetrofosmin scintigraphy for predicting resistance to chemotherapy: a critical review of clinical data
Christophe Van De Wiele
Sylvie Rottey
Ingeborg Goethals
J BUSCOMBE
Simon Van Belle
F DE VOS
Rudi Dierckx
A2
Journal Article
in
NUCLEAR MEDICINE COMMUNICATIONS
2003
How does biotherapy compare with chemotherapy for cancer?
Simon Van Belle
Sylvie Rottey
VINCENT RENARD
A2
Journal Article
in
Enhancer
2003
2001
Relationship between gastric emptying and clinical and biochemical factors in chronic haemodialysis patients
Gert De Schoenmakere
Raymond Vanholder
Sylvie Rottey
Philippe Duym
Norbert Lameire
A1
Journal Article
in
NEPHROLOGY DIALYSIS TRANSPLANTATION
2001
2000
Progression of renal failure in patients with compromised renal function is not always present : evaluation of underlying disease
Sylvie Rottey
Raymond Vanholder
G De Schoenmakere
Norbert Lameire
A1
Journal Article
in
CLINICAL NEPHROLOGY
2000